Thermo Fisher Scientific Inc, the world leader in serving science, announced the opening of a new, 70,000 sq.ft. distribution center in Bracetown, County Meath, Ireland. The facility significantly expands the company’s infrastructure in Ireland, one of the world’s leading hubs for pharmaceutical and biopharmaceutical …
Coriolis Pharma celebrates the grand opening of its new U.S. headquarter and laboratory, marking the start of operations at the Alexandria Center for Advanced Technologies (ACAT) in North Carolina’s Research Triangle Park (RTP). This expansion enables Coriolis to provide its North American clients with direct access t…
Precision for Medicine (Precision), a global leader in biomarker-driven clinical research and development, has announced the opening of its new Japan office, deepening its commitment to the Asia-Pacific region and reinforcing its role as a bridge between local expertise and global development execution. Japan is the …
Norgine, a leading European specialty pharmaceutical company, announced a new £23 million investment in its Hengoed, Wales manufacturing site bringing the total investment at the facility to more than £50 million since 2022. Supported by the UK Government's Life Sciences Innovative Manufacturing Fund (LSIMF), this la…
CSL a global biopharma leader, broke ground for the expansion of its state-of-the-art manufacturing facility in Kankakee, Illinois. The expansion, a cornerstone of the company's global manufacturing growth strategy and effort to expand its U.S. production presence, was officially announced with state and local officia…
Novo Nordisk, announced an investment of 432 million euro in its facility in Monksland, Athlone, Ireland. This tabletting facility will provide significant additional manufacturing capacity for current and future Novo Nordisk GLP-1 treatments. The investment is a major strategic milestone for the company, which furth…
Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering, announced a major expansion of its UK manufacturing capabilities with the purchase of a GEA Pharma-SD® type PSD-4 solvent-capable spray dryer. …
Novartis, a leading global innovative medicines company, announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, Texas. This purpose-built RLT site will be the company’s fifth in the US and first manufacturing facility in Texas, and marks further progress in the co…
AstraZeneca announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. This investment will leverage the country’s scientific excellence, advanced manufacturing, and China-UK healthcare ecosystem collaborations to deliver cutting-edge treatments to patients across China and g…
PharmaEssentia Corporation, a global biopharmaceutical company headquartered in Taiwan with deep expertise in the development of novel biologics for hematology and oncology, and its US subsidiary PharmaEssentia USA Corporation have announced that the global corporate Board of Directors has approved an investment of ap…
Page 8 of 58